Payer Challenges & Issues in the Management of OAB:
Improving Patient Outcomes with Optimal Cost &
Treatment Strategies

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session at the 2017 Fall Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from April 20, 2018 to April 30, 2019

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
Astellas Scientific and Medical Affairs

Description:
Overactive bladder (OAB) is a highly prevalent condition that occurs about twice as frequently in women as in men, and while OAB is not considered a normal part of aging, it does become more predominant with advanced age. OAB has a significant impact on quality of life (QoL), co-morbidities and cost; sufferers are two to three times more likely to experience disturbed sleep, overeating, poor self-esteem, and depression. Despite its impact, OAB remains underdiagnosed and undertreated. Screening and evaluating patients is of utmost importance in order to improve diagnosis and patient QoL. Once diagnosed, a stepwise progression is recommended to manage the disease. Multiple options of treatment are available, providing a tailored approach to individualize treatment based upon a patient’s expectation and goal for treatment, their co-morbidities, symptoms, and the side-effects of treatments. What works and does not work will vary patient to patient and it’s important to keep communications open to determine if a patient is unable to remain compliant to treatment due to side-effects or cost.

Upon Completion of this activity, participants will be able to:

  • Analyze the consequences and the clinical, societal, and economic burden of underdiagnosed and mismanaged overactive bladder (OAB)

  • Differentiate among the costs, safety, efficacy and mechanisms of action in anti-muscarinic agents and ß3-adrenoceptor agonists in OAB management

  • Discuss available data, national quality measures, individualized patient needs, and clinical/economic consequences of treatments into evidence-based formulary decisions and protocols

  • Apply methods to enable optimal cost management of current therapies to be realized by multiple OAB stakeholders including managed care organizations

  • Identify barriers to patient adherence to management of OAB and how such barriers may be effectively addressed
     

Faculty: Craig V. Comiter, MD
Professor of Urology
Obstetrics and Gynecology
Stanford University Medical Center

Disclosure:

Dr. Comiter has no relevant financial relationships to disclose. His presentation has been peer reviewed for any bias.
 
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This presentation is supported by an educational grant from
Astellas Scientific and Medical Affairs

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue